Sale!

Tofranil (Imipramine)

£0.00

-28%
Tofranil (imipramine) is a medicine used to treat depression. It may also be prescribed for other conditions such as certain types of bedwetting in children (where appropriate). It works by affecting chemicals in the brain that influence mood and sleep. Take it exactly as directed by your healthcare professional. Common side effects can include drowsiness, dry mouth, constipation and dizziness. Avoid alcohol and seek urgent advice for severe reactions.

Tofranil (Imipramine) — Patient Information (UK)

Tofranil is a medicine containing imipramine, a tricyclic antidepressant (TCA). It is used in the treatment of certain mental health conditions and, in some cases, specific bladder problems in children and adults. This page explains what Tofranil is, how it works, how it is taken, important safety information, and what to expect in everyday use in the UK.

Quick product summary

Product Details
Brand name Tofranil
Active ingredient Imipramine (as imipramine hydrochloride)
Medicine type Tricyclic antidepressant (TCA)
Common forms Tablets (strengths vary by product/market)
Uses Depression; and certain types of nocturnal enuresis (bedwetting) in selected patients
How it’s taken By mouth, usually once or split doses depending on the condition

How Tofranil works (mechanism of action)

Imipramine helps improve symptoms of depression and related conditions through effects on brain chemical messengers (neurotransmitters). The precise mechanism is complex, but the main actions include:

  • Inhibition of reuptake of neurotransmitters such as serotonin and noradrenaline, which can help improve mood and emotional balance.
  • Anticholinergic effects (blocking certain nerve signals), which can contribute to side effects such as dry mouth, constipation, and blurred vision.
  • Antihistamine and sedative effects, which can influence sleep and drowsiness.

For bedwetting, Tofranil’s effects on bladder control and sleep architecture may reduce nighttime urine production and improve arousal during sleep, helping reduce episodes of enuresis in suitable patients.

Pharmacokinetics (how the body handles the medicine)

Pharmacokinetics describes how imipramine is absorbed, processed, and removed from the body. Key points include:

  • Absorption: Imipramine is absorbed after taking tablets by mouth.
  • Distribution: It distributes into body tissues, including the brain.
  • Metabolism: Imipramine is mainly broken down in the liver by enzymes including CYP pathways (notably CYP2D6 among others), producing active and inactive metabolites.
  • Elimination: Metabolites are removed primarily through the kidneys (urine) and to some extent via bile/feces.
  • Half-life: The active effects can last beyond a single dose. People can build steady levels over time, which is why doses may be adjusted gradually.

These characteristics mean that imipramine can take time to reach full effect and that stopping suddenly can lead to withdrawal-like symptoms for some people.

What it’s used for (indications)

Tofranil is used for:

  • Depression (particularly when a TCA is appropriate based on clinical factors).
  • Nocturnal enuresis (bedwetting) in selected children and adolescents (typically after other measures have been considered). Use is usually limited to cases where it is appropriate and safe.

When you should start to feel better (timing)

Timing can vary by individual and condition:

  • Depression: Some improvement may be noticed after about 1–2 weeks, but a fuller effect often takes several weeks. Continue taking as directed.
  • Bedwetting: Some effect may occur earlier, but treatment plans commonly involve careful follow-up and review to assess benefit and safety.

If you do not feel any benefit after the expected period, speak with a healthcare professional. Do not change the dose yourself.

How to take Tofranil (dosing and administration)

Dosing depends on the condition, age, overall health, and response to treatment. The aim is to use the lowest effective dose for the shortest appropriate duration.

General dosing principles

  • Start low, go slow: Many people begin with a lower dose to reduce side effects, then the dose may be adjusted gradually.
  • Follow the schedule: Imipramine is often taken in the evening due to possible drowsiness, but some regimens use divided doses.
  • Do not stop suddenly: Abrupt discontinuation can increase the risk of withdrawal symptoms and mood changes.

Example dosing patterns (for understanding)

The exact dose range should be confirmed with the product label and prescriber guidance. Below are typical patterns used in clinical practice:

  • Depression: Doses may start low and increase over time based on response and tolerability.
  • Nocturnal enuresis: In children, dosing is often tailored to weight/age and usually given at night.

Important: Always use the dose your clinician recommends and check the strength of your tablets. If you are unsure, speak to a pharmacist.

Can you take it with food?

Many people can take Tofranil with or without food, but food may help if the medicine causes stomach upset. As a general guide:

  • If Tofranil upsets your stomach, take it with a light meal or after food.
  • Try to keep dosing times consistent day to day.

Always refer to your specific product packaging instructions for the most accurate advice.

Alcohol interactions and safety

Alcohol can increase certain side effects of Tofranil, particularly:

  • Drowsiness and slowed reaction times
  • Increased dizziness
  • Worsening mood symptoms for some people

To reduce risk, it’s generally best to avoid alcohol or keep intake minimal. If you plan to drink alcohol, ask a healthcare professional how much is safe for you.

Interactions with other medicines

Imipramine can interact with a range of medicines. Interactions may affect:

  • how imipramine works (efficacy)
  • side effects (tolerability)
  • heart rhythm (risk of abnormal rhythm)

Medicines to be particularly careful with

  • Other antidepressants (especially SSRIs, SNRIs, MAOIs, or other TCAs): combining antidepressants can raise the risk of serotonin-related side effects and/or excessive TCA levels in the blood.
  • Medicines that affect heart rhythm or can prolong QT interval: imipramine may increase risk when used with certain antiarrhythmics or some antibiotics/antifungals.
  • Strong CYP inhibitors (some medicines that affect metabolism): these can raise imipramine blood levels and side effects.
  • Anticholinergic medicines (e.g., for overactive bladder or some allergies): may increase anticholinergic side effects like constipation, dry mouth, and blurred vision.
  • Sedatives (including some sleep aids, opioids, or benzodiazepines): can increase drowsiness and impair driving ability.
  • St John’s wort (herbal antidepressant): may affect drug levels and increase risk of adverse reactions.

What to do

  • Keep an up-to-date list of all medicines and supplements you take.
  • Tell a pharmacist about any new medicine, including over-the-counter products.
  • If you feel unwell after starting a new combination, contact a healthcare professional promptly.

Safety profile and important warnings

Like all medicines, Tofranil can cause side effects. Many are dose-related and improve with time, but some effects require urgent attention.

Common side effects

  • Drowsiness or tiredness
  • Dizziness, especially when standing up
  • Dry mouth
  • Constipation
  • Blurred vision
  • Increased sweating
  • Nausea or stomach discomfort
  • Tremor or feeling restless
  • Weight change (sometimes gain)

Less common but serious risks

  • Heart rhythm effects: TCAs can sometimes affect the electrical activity of the heart. Risk may be higher in people with existing heart disease, low potassium/magnesium, or when combined with certain medicines.
  • Allergic reactions: seek urgent advice if you develop swelling of the face/lips, breathing difficulties, or severe rash.
  • Seizures: risk can increase with higher doses or certain risk factors.
  • Severe mood changes: report immediately if you experience worsening depression, agitation, or suicidal thoughts.
  • Serotonin-related symptoms (when combined with other serotonergic medicines): symptoms can include restlessness, confusion, sweating, trembling, diarrhoea, and fever. Urgent medical review is needed if symptoms are significant.

Children and young people

For conditions such as bedwetting, careful selection and monitoring are important. Young people may be more vulnerable to changes in mood and behaviour. Any concerning mental health symptoms should be discussed promptly with a healthcare professional.

Driving and operating machinery

Tofranil can cause drowsiness and blurred vision, particularly when starting or when the dose changes. Avoid driving or using machinery until you know how the medicine affects you.

Overdose risk

TCAs can be dangerous in overdose. If you suspect an overdose, seek urgent medical attention immediately. Keep tablets out of reach of children and do not share medication.

Practical use tips

  • Take it at the same time each day: consistency helps with both effectiveness and side effects.
  • Plan for drowsiness: if you feel sleepy, taking it in the evening may help (follow your regimen).
  • Manage dry mouth: sugar-free sweets/chewing gum, frequent sips of water, and good oral hygiene.
  • Prevent constipation: increase fibre, drink fluids, and consider discussing suitable stool-softening options if needed.
  • Stand up slowly: if you feel light-headed, rise gradually to reduce dizziness.
  • Keep follow-up appointments: especially during the early weeks or when monitoring is required.

What to do if you miss a dose

If you forget a dose, take it when you remember unless it is close to the time of your next dose. In most cases:

  • Do not double up to make up for a missed dose.
  • If you are unsure, ask a pharmacist for advice based on your dosing schedule.

Stopping Tofranil safely

Stopping imipramine should be done under clinical guidance. Stopping suddenly may cause symptoms such as:

  • nausea
  • headache
  • sleep disturbance
  • flu-like feelings
  • return or worsening of symptoms

A gradual reduction plan can help minimise discomfort and relapse risk.

Alternative options to consider

Depending on the condition being treated, alternatives may include other antidepressants or bladder-focused treatments. Options vary by individual factors and may include:

  • Other antidepressants (e.g., SSRIs/SNRIs) for depression
  • For enuresis: behavioural strategies and, in some cases, medicines that reduce urine production at night
  • Non-medicine approaches: talking therapies for depression; bedwetting support plans such as fluid timing and alarm therapy

A clinician can help decide which alternative is most suitable, balancing benefits, side effects, and your medical history.

UK market and legal context (for patients)

In the United Kingdom, medicines like Tofranil are regulated and supplied in line with UK medicines legislation and guidance for safe prescribing and use. Medicines with antidepressant activity are subject to specific advice on monitoring, especially in younger people.

Availability depends on product form and strength, and supply can vary between suppliers. Always check the packaging and the Medicine Guidance on the leaflet provided with your product.

Recent guidance and monitoring (what matters now)

UK clinical practice continues to emphasise:

  • Careful assessment before starting antidepressants, including risk evaluation for worsening mood or suicidal thoughts (particularly in younger people).
  • Regular review during the first weeks of treatment and after dose changes.
  • Attention to interactions (especially with other medicines that affect serotonin or heart rhythm).
  • Appropriate duration and a safe plan for discontinuation.

If you have concerns, speak with a healthcare professional or pharmacist—early advice can prevent complications.

Delivery and availability (UK)

Online pharmacies in the UK may offer delivery services depending on availability, stock levels, and the medicine’s supply classification. Delivery times vary by supplier and location.

  • Availability: stock can change, especially for less commonly requested strengths.
  • Delivery: estimated delivery dates are typically shown at checkout or in order updates.
  • Packaging: medicines are usually dispatched in protective packaging with patient information included.

If Tofranil is not currently available, the pharmacy may offer an alternative strength or an equivalent option where appropriate, or advise when it will return to stock.

FAQ

1) What is Tofranil used for?

Tofranil (imipramine) is used for depression and, in selected patients, for nocturnal enuresis (bedwetting). The suitability depends on age, diagnosis, and medical history.

2) How long does Tofranil take to work?

For depression, some people notice improvement after 1–2 weeks, but full benefit usually takes several weeks. For bedwetting, benefit may be seen sooner, but it requires monitoring and follow-up to confirm effectiveness.

3) Should I take it in the morning or evening?

Many regimens use the evening because of drowsiness, but some schedules may be split. Follow your specific dosing plan. If you feel overly sleepy or wired, speak to a pharmacist or clinician.

4) Can I take Tofranil with food?

Often yes. Taking with food can help if you experience nausea or stomach discomfort. Keep dosing times consistent.

5) Can I drink alcohol while taking Tofranil?

It’s generally best to avoid or minimise alcohol. Alcohol can worsen drowsiness, dizziness, and mood symptoms. Ask a healthcare professional if you’re unsure about what’s safe for you.

6) What medicines should I avoid?

Interactions can occur with other antidepressants, sedatives, anticholinergic medicines, and some drugs that affect heart rhythm or the way imipramine is metabolised. Always check with a pharmacist if you start a new medicine.

7) Are there special precautions for heart conditions?

Yes. TCAs may affect heart rhythm. People with heart disease, electrolyte imbalances, or relevant risk factors need careful assessment and monitoring, especially if taking other interacting medicines.

8) What side effects are common?

Common side effects include drowsiness, dizziness, dry mouth, constipation, blurred vision, and sweating. Many improve with time or dose adjustment.

9) What should I do if I feel worse after starting?

Contact a healthcare professional promptly—especially if you experience increased agitation, worsening depression, or thoughts of self-harm. Do not stop the medicine abruptly without advice.

10) How should I stop taking Tofranil?

Do not stop suddenly. A gradual reduction plan helps reduce the chance of withdrawal symptoms and relapse. Seek guidance from a clinician or pharmacist.

11) Can I use it for bedwetting?

In the UK, Tofranil may be used for nocturnal enuresis in selected children and young people under appropriate medical supervision, alongside behavioural measures where needed.

12) Where can I find more detailed information?

Refer to the patient information leaflet provided with your specific Tofranil product. If you have questions, speak to a pharmacist who can explain how the medicine applies to your situation.

Further help and when to seek urgent advice

Get urgent medical help if you experience symptoms that could indicate a serious reaction, such as:

  • chest pain, fainting, severe dizziness, or signs of an abnormal heart rhythm
  • swelling of the face/lips, trouble breathing, or severe rash
  • severe confusion, high fever, or uncontrollable shaking (particularly if combined with other serotonergic medicines)
  • thoughts of self-harm or severe worsening of mental health

This page is for general patient information and does not replace advice from healthcare professionals. If you have questions about Tofranil, side effects, or suitability, speak to a pharmacist or clinician.

Additional information

Dosage: No selection

25mg, 50mg, 75mg

Package: No selection

30 pill, 60 pill, 90 pill, 120 pill, 180 pill, 360 pill